Michel Tsang-A-Sjoe - Concepedia

Author

Michel Tsang-A-Sjoe

Amsterdam UMC Location Vrije Universiteit Amsterdam ORCID

Also Known As

I Castrejón, M Tsang-A-Sjoe, M W P Tsang A Sjoe, M. Tsang a Sjoe, M. Tsang-A-Sjoe, M.W. Tsang-A-Sjoe, M.W.-P. Tsang-A-Sjoe, M.W.P. Tsang-A-Sjoe, MW Tsang-a Sjoe, MW Tsang-a-Sjoe

Publications

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam University of Amsterdam Amsterdam UMC Location University of Amsterdam Sanquin The University of Melbourne

About

Michel Tsang-A-Sjoe is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in immunology, medicine, and rheumatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	40
2	Immunology	2	2	40
3	Allergy	1	1	29
4	Biostatistics	1	1	29
5	Pathology	1	1	11

Michel Tsang-A-Sjoe

Publications

722

Citations

H-Index

Page 1

	Year	Citations
2021 DORIS definition of remission in SLE: final recommendations from an international task force Ronald van Vollenhoven, George Βertsias, Andrea Doria, Lupus Science & Medicine	2021	299
Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus Michel Tsang-A-Sjoe, Irene E. M. Bultink, Maaike Heslinga, Lara D. Veeken	2016	170
Fc-gamma receptor polymorphisms differentially influence susceptibility to systemic lupus erythematosus and lupus nephritis Michel Tsang-A-Sjoe, Sietse Q. Nagelkerke, Irene E. M. Bultink, Lara D. Veeken	2016	75
The relationship between remission and health-related quality of life in a cohort of SLE patients Michel Tsang-A-Sjoe, Irene E. M. Bultink, Maaike Heslinga, Lara D. Veeken	2018	52
B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients Stefan Bruijnen, Michel Tsang-A-Sjoe, Hennie G. Raterman, Arthritis Research & Therapy	2016	46
Anti-Hinge Antibodies Recognize IgG Subclass– and Protease-Restricted Neoepitopes Willem J.J. Falkenburg, Dirkjan van Schaardenburg, Pleuni Ooijevaar‐de Heer, The Journal of Immunology	2016	30
A multi-parameter response prediction model for rituximab in rheumatoid arthritis Tamarah D. de Jong, Jérémie Sellam, Rabia Agca, Joint Bone Spine Rheumatoid DisorderRheumatologyAutoimmune DiseaseAllergyRheumatic Diseases	2017	29
Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity Michel Tsang-A-Sjoe, Irene E. M. Bultink, L.-A. Korswagen, Molecular Immunology RheumatologyComplement SystemImmunogeneticsAutoimmune DiseaseSystemic Lupus Erythematosus	2017	11
Pharmacodynamic monitoring of (immuno)proteasome inhibition during bortezomib treatment of a critically ill patient with lupus nephritis and myocarditis Karina A. de Groot, Michel Tsang-A-Sjoe, Denise Niewerth, Lupus Science & Medicine	2015	10

Page 1